
GSK, Moderna settle patent dispute over Moderna COVID, RSV shots
来源:Reuters发布于 2026-11-06
British drugmaker GSK has settled lawsuits that accused Moderna's [COVID-19 vaccines Spikevax and mNEXSPIKE and RSV shot mResvia of infringing its patents, the companies said on Friday.
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。